Skip to main content
. 2012 Jul 3;70(2):305–313. doi: 10.1007/s00280-012-1916-9

Fig. 1.

Fig. 1

Mean (sd) plasma concentration–time profiles of abiraterone after single and multiple dose administration of abiraterone acetate to patients with metastatic CRPC. C1D1 = Cycle 1 Day 1; C1D8 = Cycle 1 Day 8; C2D1 = Cycle 2 Day 1; CRPC = castration-resistant prostate cancer